|
| Exchange Disseminated Time 28/02/2019 16:49:31 | The Exchange has sought clarification from Aurobindo Pharma Ltd with respect to news article appearing on www.business-standard.com February 27, 2019, titled "Lacunae in Aurobindo Pharma's Medak facility in Andhra, says FDA report".
The reply is awaited. |
|
|